News & Events
26
December 2024

GalNAc plays a crucial role in enhancing the targeted delivery of small nucleic acid drugs, particularly for liver-targeted therapies. Here's how it works: 

24
December 2024

Various modifications are applied to small nucleic acids to enhance their stability, reduce immunogenicity, and improve targeting. Below are the most commonly used modifications and their primary functions: 

19
December 2024

Several delivery strategies are employed to overcome the challenges of nucleic acid stability, cellular uptake, and tissue targeting for small nucleic acid drugs. 

17
December 2024

Despite their therapeutic potential, small nucleic acid drugs face several significant challenges in development: 

17
December 2024

Small nucleic acid drugs exhibit distinct features that set them apart from small molecule drugs and antibody-based therapies.

Add:17800 Castleton St, Ste 665, City of industry, CA 91748, USA

Tel +1 408-828-0438

Email: [email protected]

@ GENCEFE BIOTECH LIMITED